Erratum to "Analysing UK clinicians' understanding of cognitive symptoms in major depression: A survey of primary care physicians and psychiatrists" [J. Affect. Disord. 207 (2017) 346-352].
Sign Up to like & getrecommendations! Published in 2017 at "Journal of affective disorders"
DOI: 10.1016/j.jad.2017.04.023
Abstract: The publisher regrets the omission of the following Acknowledgements, Role of funding source and Conflict of interest information in the original publication. RHMW, KB, GMG, JH, CK, JR, SS and AHY contributed as authors on… read more here.
Keywords: received payment; research; lundbeck; eli lilly ... See more keywords
Associations between childhood maltreatment and inflammatory markers
Sign Up to like & getrecommendations! Published in 2019 at "BJPsych Open"
DOI: 10.1192/bjo.2018.80
Abstract: Background Childhood maltreatment is one of the strongest predictors of adulthood depression and alterations to circulating levels of inflammatory markers is one putative mechanism mediating risk or resilience. Aims To determine the effects of childhood… read more here.
Keywords: lundbeck; eli lilly; levels inflammatory; inflammatory markers ... See more keywords
Esketamine nasal spray shows greater improvement in health-related quality of life over 32 weeks versus quetiapine extended release in patients with treatment resistant depression
Sign Up to like & getrecommendations! Published in 2024 at "European Psychiatry"
DOI: 10.1192/j.eurpsy.2024.749
Abstract: Introduction In ESCAPE-TRD esketamine nasal spray (ESK-NS) significantly increased the probability of achieving remission at Week (Wk) 8 and being relapse‑free through Wk32 after remission at Wk8 versus (vs) quetiapine extended release (Q-XR) in patients… read more here.
Keywords: support; johnson; janssen; research ... See more keywords